Skip to main content
  • Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment.  Check your account now to learn when your revalidation is due. More information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Meeting Results for: March 9, 2011

Drug Name Review Type Committee Recommendation Prior Approval Status � Final Determination
Pradaxa New Drug Initial Review Remove Prior Approval Requirement Prior Approval Required
Veregan New Drug Initial Review Remove Prior Approval Requirement Prior Approval Required
Latuda New Drug Initial Review Remove Prior Approval Requirement Prior Approval Required
Kapvay New Drug Initial Review Require Prior Approval Prior Approval Required
Fanapt New Drug Initial Review Remove Prior Approval Requirement Prior Approval Required
Pegasys PDL Appeal Remove Prior Approval Requirement Prior Approval Requirement Removed